Karaganda plant received registration certificate for Sputnik V


The Ministry of Health of Kazakhstan issued a registration certificate of the anti-COVID-19 Sputnik V vaccine for the Karaganda Pharmaceutical Complex (KPK), TASS reports citing an interdepartmental commission of prevention of spread of coronavirus under the government of the republic.

The Karaganda Pharmaceutical Complex received a registration certificate for the Gam-Covid-Vak vaccine (Sputnik V). On February 13 of this year, the drug received the opinion of the expert commission of the Ministry of Health of Kazakhstan on the safety, quality and effectiveness of the vaccine based on the results of the consideration of the materials of the registration dossier. Due to the support of the Republic Ministry of Health, a registration certificate was issued on February 15″, the statement said.

In January, a pilot batch of Sputnik V vaccine, released in Kazakhstan, successfully passed a quality test at the Gamalei National Research Center for Epidemiology and Microbiology. On January 27, First Vice Minister of Health of Kazakhstan Marat Shoranov announced that the KPK started the first vaccine batch production.

By the end of February, the republic is expected to use the Sputnik V drug produced on the basis of the Karaganda pharmaceutical complex. Since the second quarter of this year, they intend to connect the vaccine of Kazakhstan-made QazCovid-in to the vaccination process of the population, which is currently undergoing phase III clinical trials.